Last reviewed · How we verify
NCT04043637
Early Urinary Continence After Radical Prostatectomy: Surgical Procedure and Anatomic Landmarks
trial in Prostatic Cancer in 120 participants. Completed in 10 April 2019.
3 December 2018
Quick facts
| Lead sponsor | Consorci Sanitari Integral |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 23 April 2012 |
| Primary completion | 3 December 2018 |
| Estimated completion | 10 April 2019 |
Conditions studied
- Prostatic Cancer — all drugs for Prostatic Cancer →
- Surgical Procedure, Unspecified — all drugs for Surgical Procedure, Unspecified →
- Urinary Incontinence — all drugs for Urinary Incontinence →
Sponsor
Consorci Sanitari Integral — full company profile →
Who can join
Adults 40 to 75, male only, with Prostatic Cancer or Surgical Procedure, Unspecified. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study describes how to perform a correct prostatic apex and membranous urethra in order to preserve all anatomical elements that are necessary to achieve a very fast urinary continence after open/laparoscopic/robotic radical prostatectomy, avoiding positive surgical margins at this level.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04043637
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prostatic Cancer
Currently open trials in the same condition.
- NCT06819215 — Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
- NCT05740956 — A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors · Phase 1 · recruiting
- NCT05184790 — LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology · recruiting
- NCT03354416 — Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer · recruiting
- NCT03173924 — 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer · Phase 2 · active not recruiting
Other Consorci Sanitari Integral trials
Trials by the same sponsor.
- NCT06993220 — Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients · recruiting
- NCT06533839 — Prevention of Parastomal Hernias With a Preformed Three-dimensional, Funnel-shaped Mesh · NA · not yet recruiting
- NCT07286552 — Breathing Pattern Description in Pneumonia Patients · active not recruiting
- NCT05815914 — Nutritional Support and Telemedicine · NA · unknown
- NCT04037449 — Transversus Abdominis Plane Block in the Analgesia of Acute Pancreatitis · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04043637 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Consorci Sanitari Integral
- Last refreshed: 6 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04043637.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing